TY - JOUR
T1 - Nuclear β-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions
AU - Bhattacharya, Baishali
AU - Dilworth, Harrison Parry
AU - Iacobuzio-Donahue, Christine
AU - Ricci, Francesca
AU - Weber, Kristin
AU - Furlong, Mary A.
AU - Fisher, Cyril
AU - Montgomery, Elizabeth
PY - 2005/5/1
Y1 - 2005/5/1
N2 - Deep fibromatoses (desmoid tumors) are clonal myofibroblastic proliferations that are prone to aggressive local recurrences but that do not metastasize. They must be distinguished from a host of fibroblastic and myofibroblastic lesions as well as from smooth muscle neoplasms. Virtually all deep fibromatoses have somatic β-catenin or adenomatous polyposis coli (APC) gene mutations leading to intranuclear accumulation of β-catenin. Since low-grade sarcomas in general lack β-catenin and since reactive proliferations would not be expected to have it, we predicted that nuclear β-catenin expression would be detected in deep fibromatoses but absent in other entities in the differential diagnosis. We evaluated the role of β-catenin to help differentiate distinguish deep fibromatoses from congeners. Formalin-fixed, paraffin-embedded sections from 21 lesions from 20 patients with deep fibromatoses were stained with monoclonal β-catenin antibody (Transduction Laboratories) and compared with low-grade fibromyxoid sarcoma (n = 12), leiomyosarcoma (n = 10), various other fibrosarcoma variants (n = 13, including 3 myofibrosarcomas, 3 sclerosing epithelioid fibrosarcomas, 5 low-grade fibrosarcomas, 1 classic fibrosarcoma arising in dermatofibrosarcoma protuberans, 1 inflammatory myxohyaline tumor/myxoinflammatory fibroblastic sarcoma), myofibroma/myofibromatosis (n = 12), nodular fasciitis (n = 11), and scars (n = 9). Nuclear and cytoplasmic staining was assessed. All 21 examples of deep fibromatosis displayed nuclear β-catenin (focal nuclear staining in one case to 90% staining). All other lesions tested (n = 67) lacked nuclear labeling for β-catenin, showing only cytoplasmic accumulation. β-Catenin immunohistochemistry separates deep fibromatosis from entities in the differential diagnosis, a finding that can be exploited for diagnosis. Most fibromatoses have diffuse nuclear staining although occasional examples only focally label.
AB - Deep fibromatoses (desmoid tumors) are clonal myofibroblastic proliferations that are prone to aggressive local recurrences but that do not metastasize. They must be distinguished from a host of fibroblastic and myofibroblastic lesions as well as from smooth muscle neoplasms. Virtually all deep fibromatoses have somatic β-catenin or adenomatous polyposis coli (APC) gene mutations leading to intranuclear accumulation of β-catenin. Since low-grade sarcomas in general lack β-catenin and since reactive proliferations would not be expected to have it, we predicted that nuclear β-catenin expression would be detected in deep fibromatoses but absent in other entities in the differential diagnosis. We evaluated the role of β-catenin to help differentiate distinguish deep fibromatoses from congeners. Formalin-fixed, paraffin-embedded sections from 21 lesions from 20 patients with deep fibromatoses were stained with monoclonal β-catenin antibody (Transduction Laboratories) and compared with low-grade fibromyxoid sarcoma (n = 12), leiomyosarcoma (n = 10), various other fibrosarcoma variants (n = 13, including 3 myofibrosarcomas, 3 sclerosing epithelioid fibrosarcomas, 5 low-grade fibrosarcomas, 1 classic fibrosarcoma arising in dermatofibrosarcoma protuberans, 1 inflammatory myxohyaline tumor/myxoinflammatory fibroblastic sarcoma), myofibroma/myofibromatosis (n = 12), nodular fasciitis (n = 11), and scars (n = 9). Nuclear and cytoplasmic staining was assessed. All 21 examples of deep fibromatosis displayed nuclear β-catenin (focal nuclear staining in one case to 90% staining). All other lesions tested (n = 67) lacked nuclear labeling for β-catenin, showing only cytoplasmic accumulation. β-Catenin immunohistochemistry separates deep fibromatosis from entities in the differential diagnosis, a finding that can be exploited for diagnosis. Most fibromatoses have diffuse nuclear staining although occasional examples only focally label.
KW - Fibromatosis
KW - Leiomyosarcoma
KW - Low-grade fibromyxoid sarcoma
KW - Myofibroma
KW - Myofibromatosis
KW - Myofibrosarcoma
KW - Nodular fasciitis
KW - Scar
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=17744378169&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17744378169&partnerID=8YFLogxK
U2 - 10.1097/01.pas.0000157938.95785.da
DO - 10.1097/01.pas.0000157938.95785.da
M3 - Article
C2 - 15832090
AN - SCOPUS:17744378169
SN - 0147-5185
VL - 29
SP - 653
EP - 659
JO - American Journal of Surgical Pathology
JF - American Journal of Surgical Pathology
IS - 5
ER -